Breo Ellipta 25 ug/1

Active Ingredient:
Form:
Brand:
Origin:

Buy Breo Ellipta 25 ug/1

Breo Ellipta 25 ug/1 is a respiratory medication combining fluticasone furoate and vilanterol trifenatate. It is designed for inhalation use and is commonly used for managing chronic respiratory conditions. This powder-based inhaler is manufactured by GlaxoSmithKline LLC in the USA.

Strength

25 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0859-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER

Storage

Not specified

Manufacturer

GlaxoSmithKline LLC

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below with your details, and a member of our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Breo Ellipta 25 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The medication works by reducing inflammation and relaxing the muscles in the airways, making it easier to breathe. It is often prescribed for long-term management rather than for immediate relief of symptoms.

Side Effects

  • Common effects of Breo Ellipta 25 ug/1 may include throat irritation, headache, and hoarseness. Some users might experience a mild increase in heart rate or tremors. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Breo Ellipta 25 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with a history of heart conditions, high blood pressure, or thyroid problems should use this medication with caution. Always store the inhaler in a clean, dry place and keep it out of reach of children.

Avoid Interactions

  • Breo Ellipta 25 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

References

FAQ's

Breo Ellipta 25 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma.

Breo Ellipta 25 ug/1 is designed for inhalation use. Follow the instructions provided by your healthcare professional for proper administration.

Common side effects may include throat irritation, headache, and hoarseness. Some users might experience a mild increase in heart rate or tremors.

Breo Ellipta 25 ug/1 may be available for purchase online from authorized retailers. Ensure you are buying from a reputable source.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. It is not exhaustive and may not cover all medical conditions, treatments, or precautions. Always consult a qualified healthcare professional regarding any medical concerns. Do not ignore or delay seeking medical advice based on information provided here.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer / TM Owner" section in compliance with statutory requirements.

By continuing to access or use this website, you acknowledge and agree to the terms set forth herein. If you do not consent to these terms, you are advised to discontinue browsing immediately. Should you identify any inaccuracy, infringement, or other concern, you are encouraged to promptly report the matter for review and appropriate action. If you wish to request the removal of a product or any part of its content, please contact us at legal@gnhindia.com.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form illustration

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment confirmation

03

Confirm & Make Payment

Discuss any queries you may have, approve the estimate, and complete your payment.

Worldwide medicine delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence in pharmaceutical distribution.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001 Certification

URS ISO 9001 Certification

FDA Maharashtra License

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT